Among the most interesting results, we identified minocycline, an antibiotic, and anti‐inflammatory drug targeting CASP3 and TNF. Minocycline has been very recently proposed to alleviate the effects of SARS‐CoV‐2 severe infection in the central nervous system (Oliveira et al,2020) (see extended results in Appendix 2). Here, TNF is linked to infection.